Viking Therapeutics (NASDAQ: VKTX)
$25.62
(-0.7%)
-$0.17
Price as of April 24, 2025, 3:16 p.m. ET
Key Data Points
Current Price
$25.62
Daily Change
(-0.7%) -$0.17
Day's Range
$24.90 - $26.75
Previous Close
$25.79
Open
$26.09
Beta
1.22
Volume
2,552,887
Average Volume
4,618,274
Sector
Market Cap
$3B
Market Cap / Employee
$80M
52wk Range
$18.92 - $81.86
Revenue
-
Gross Margin
0%
Dividend Yield
N/A
EPS
-$1.01
CAPs Rating
-
Industry
Biotechnology
The Motley Fool Investing Philosophy: We generally recommend investors buy shares of at least 25 stocks and hold them for at least 5 years. Learn More
Viking Therapeutics Return vs. S&P
1 Year | 5 Year | 5 Year Annualized | Since IPO |
---|
Viking Therapeutics Company Info
Viking Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the development of therapies for metabolic and endocrine disorders. The company was founded by Brian Lian and Michael A. Dinerman on September 24, 2012 and is headquartered in San Diego, CA.
News & Analysis
The Fool has written over 200 articles on Viking Therapeutics.
Featured Article
2 Stocks Down by 25% or More This Year to Buy and Hold
Prosper Junior Bakiny | Apr 17, 2025
Featured Article
Down 71%, Should You Buy the Dip on Viking Therapeutics Stock?
Dan Victor | Apr 14, 2025
Why Eli Lilly, Novo Nordisk, and Viking Therapeutics Stocks All Popped Today
Rich Smith | Apr 14, 2025
Pfizer bows, but is not entirely out of the GLP-1 race.
Will Viking Therapeutics Be a Top Healthcare Stock in 10 Years?
David Jagielski | Apr 10, 2025
Viking Therapeutics, Down 40%, Just Reached a New Milestone. Is the Stock a Buy Now?
Adria Cimino | Apr 2, 2025
The Smartest Biotech Stocks to Buy With $50
Prosper Junior Bakiny | Apr 1, 2025
1 Biotech Stock Down 52% That Could Soar by 233%, According to Wall Street
Prosper Junior Bakiny | Mar 20, 2025
Down 65% From Its 52-Week High, Is Viking Therapeutics Stock a Bargain Buy?
David Jagielski | Mar 18, 2025
Financial Health
General
Q4 2024 | YoY Change |
---|
Revenue Growth Rate
Earnings Per Share Growth Rate
Assets
Q4 2024 | YoY Change |
---|
Liabilities
Q4 2024 | YoY Change |
---|
Ratios
Q4 2024 | YoY Change |
---|
Cash Flow
Q4 2024 | YoY Change |
---|
Valuation
Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | YoY Change |
---|
Premium Investing Services
Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.